1,881 Shares in Align Technology, Inc. $ALGN Purchased by MBB Public Markets I LLC

Key Points

• MBB Public Markets I LLC made a new investment of $299,000 in Align Technology, acquiring 1,881 shares of the company during the first quarter.
• Align Technology reported Q2 earnings of $2.49 per share, falling short of the $2.57 estimate, with revenue also below expectations at $1.01 billion.
• Align Technology announced a stock buyback program allowing the company to repurchase $200 million in shares, indicating management's belief that the stock is undervalued.

MBB Public Markets I LLC purchased a new stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,881 shares of the medical equipment provider's stock, valued at approximately $299,000.

Other hedge funds have also recently made changes to their positions in the company. Orion Capital Management LLC purchased a new stake in shares of Align Technology in the fourth quarter worth $42,000. Compagnie Lombard Odier SCmA bought a new position in Align Technology in the 1st quarter worth about $32,000. Center for Financial Planning Inc. bought a new position in Align Technology in the 1st quarter worth about $35,000. SVB Wealth LLC purchased a new stake in shares of Align Technology in the 1st quarter valued at about $36,000. Finally, Mather Group LLC. boosted its position in shares of Align Technology by 375.0% during the 1st quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider's stock valued at $69,000 after acquiring an additional 345 shares during the last quarter. 88.43% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Align Technology

In related news, CEO Joseph M. Hogan purchased 7,576 shares of Align Technology stock in a transaction that occurred on Friday, August 1st. The shares were bought at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the transaction, the chief executive officer directly owned 184,945 shares of the company's stock, valued at $24,318,418.05. This represents a 4.27% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.66% of the company's stock.

Align Technology Stock Up 0.5%

Shares of ALGN traded up $0.65 during mid-day trading on Wednesday, hitting $132.47. 143,732 shares of the company's stock traded hands, compared to its average volume of 1,221,272. The firm has a market capitalization of $9.60 billion, a P/E ratio of 22.33, a PEG ratio of 1.48 and a beta of 1.65. The business's 50-day moving average price is $158.09 and its 200-day moving average price is $169.27. Align Technology, Inc. has a 1 year low of $127.70 and a 1 year high of $262.87.

Align Technology (NASDAQ:ALGN - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The business's revenue was down 1.6% on a year-over-year basis. During the same quarter last year, the firm earned $2.41 EPS. Align Technology has set its Q3 2025 guidance at EPS. Sell-side analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its board has authorized a stock buyback plan on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board believes its stock is undervalued.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Piper Sandler cut their price objective on Align Technology from $250.00 to $190.00 and set an "overweight" rating for the company in a report on Thursday, July 31st. Evercore ISI boosted their price target on shares of Align Technology from $200.00 to $220.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 9th. Wells Fargo & Company decreased their price target on shares of Align Technology from $246.00 to $199.00 and set an "overweight" rating on the stock in a report on Thursday, July 31st. Morgan Stanley reaffirmed an "equal weight" rating and set a $154.00 price objective (down from $249.00) on shares of Align Technology in a report on Thursday, July 31st. Finally, Mizuho set a $210.00 target price on shares of Align Technology in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Align Technology presently has a consensus rating of "Moderate Buy" and an average target price of $215.00.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.